Replies to post #9253 on CytoSorbents Corporation (CTSO)

[orangecat]

Wow. This statement is flat out false and I cited facts in an earlier post to back it up. Achieving the primary endpoint of IL-6 reduction with even fewer patients included in the analysis boosts the confidence in the results rather than reduces it.